Get the Stockscreener App
44.20
1.75%
0.76
After Hours:
44.20
Vera Therapeutics Inc stock is traded at $44.20, with a volume of 975.14K.
It is up +1.75% in the last 24 hours and up +16.87% over the past month.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
See More
Previous Close:
$43.44
Open:
$43.4
24h Volume:
975.14K
Relative Volume:
1.89
Market Cap:
$2.40B
Revenue:
-
Net Income/Loss:
$-94.30M
P/E Ratio:
-13.15
EPS:
-3.36
Net Cash Flow:
$-99.72M
1W Performance:
-0.81%
1M Performance:
+16.87%
6M Performance:
+2.50%
1Y Performance:
+222.39%
1-Day Range:
$42.35
$46.59
1-Week Range:
$42.35
$47.30
52-Week Range:
$9.24
$50.78
Vera Therapeutics Inc Stock (VERA) Company Profile
Name
Vera Therapeutics Inc
Sector
Industry
Phone
650-770-0077
Address
8000 MARINA BOULEVARD, SUITE 120, BRISBANE
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-25-24 | Initiated | Oppenheimer | Outperform |
| Jan-08-24 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-18-23 | Initiated | Raymond James | Outperform |
| Nov-10-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-16-23 | Initiated | Guggenheim | Buy |
| Jan-04-23 | Downgrade | Jefferies | Buy → Hold |
| Jan-04-23 | Downgrade | Wedbush | Outperform → Neutral |
| Jul-12-22 | Initiated | JP Morgan | Overweight |
| May-02-22 | Initiated | H.C. Wainwright | Buy |
| Apr-19-22 | Initiated | Wedbush | Outperform |
View All
Vera Therapeutics Inc Stock (VERA) Latest News
Oppenheimer gives an Outperform recommendation for Vera Therapeutics Inc (VERA) - Knox Daily
Gaining Ground: Vera Therapeutics Inc (VERA) Closes Lower at 43.44, Down -4.86 - The Dwinnex
Vera Therapeutics (NASDAQ:VERA) Trading Up 7% - MarketBeat
Deerfield Management Company L.P. Series C Reduces Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) CEO Sells $1,064,906.25 in Stock - MarketBeat
Vera Therapeutics (NASDAQ:VERA) Stock Price Down 5.8% - MarketBeat
Marshall Wace LLP Boosts Stake in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Vera Therapeutics CEO sells over $1 million in company stock - Investing.com
Vera Therapeutics, Inc. (NASDAQ:VERA) Position Boosted by Renaissance Technologies LLC - MarketBeat
Decheng Capital LLC Invests $2.52 Million in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Is Vera Therapeutics Inc. (VERA) the Best Performing Small-Cap Stock in 2024? - Insider Monkey
Is Vera Therapeutics Inc. (VERA) the Best Performing Small-Cap Stock in 2024? - Yahoo Finance
Nothing is Better Than Vera Therapeutics Inc (VERA) stock at the moment - SETE News
Decheng Capital LLC Invests $2.52 Million in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Point72 DIFC Ltd Has $1.46 Million Stake in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Affinity Asset Advisors LLC Has $13.57 Million Stock Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Ratios Uncovered: Breaking Down Vera Therapeutics Inc (VERA)’s Trailing Twelve Months Metrics - The Dwinnex
VERA overperforms with a 4.82 increase in share price - US Post News
Magnetar Financial LLC Takes $652,000 Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Samlyn Capital LLC - Defense World
First Light Asset Management LLC Acquires 569,590 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Samlyn Capital LLC - MarketBeat
Examining the Potential Price Growth of Vera Therapeutics Inc (VERA) - Knox Daily
Vera Therapeutics, Inc. (NASDAQ:VERA) Shares Bought by Integral Health Asset Management LLC - MarketBeat
Adams Street Partners LLC Buys Shares of 13,114 Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
HighVista Strategies LLC Makes New $331,000 Investment in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Cantor Fitzgerald Reiterates Overweight Rating for Vera Therapeutics (NASDAQ:VERA) - MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Stake Reduced by Avoro Capital Advisors LLC - Defense World
(VERA) On The My Stocks Page - Stock Traders Daily
American Century Companies Inc. Makes New Investment in Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
American Century Companies Inc. Takes Position in Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Insider Selling: Vera Therapeutics, Inc. (NASDAQ:VERA) Director Sells 1,177 Shares of Stock - MarketBeat
Vera Therapeutics director sells over $696k in company stock By Investing.com - Investing.com South Africa
Vera Therapeutics director sells over $696k in company stock By Investing.com - Investing.com Australia
Vera Therapeutics director sells over $696k in company stock By Investing.com - Investing.com Canada
Vera Therapeutics director sells over $696k in company stock - Investing.com
Vera Therapeutics director sells over $696k in company stock By Investing.com - Investing.com UK
Victory Capital Management Inc. Buys 22,560 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Taking a look at what insiders are doing to gauge the Vera Therapeutics Inc (VERA)’s direction - Knox Daily
Vera Therapeutics (NASDAQ:VERA) Stock Rating Upgraded by Evercore ISI - MarketBeat
Vera Therapeutics (NASDAQ:VERA) Lifted to Strong-Buy at Evercore ISI - Defense World
Does Vera Therapeutics Inc (VERA) offer a good opportunity for investors? - SETE News
Arizona State Retirement System Buys 1,250 Shares of Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Rating of “Buy” from Analysts - Defense World
Federated Hermes Inc. Buys Shares of 290,000 Vera Therapeutics, Inc. (NASDAQ:VERA) - MarketBeat
Market Watch Highlights: Vera Therapeutics Inc (VERA) Ends on an Upturn Note at 40.10 - The Dwinnex
Federated Hermes Inc. Acquires Shares of 290,000 Vera Therapeutics, Inc. (NASDAQ:VERA) - Defense World
A closer look at Vera Therapeutics Inc (VERA) is warranted - US Post News
Vera Therapeutics Inc Inc. (VERA) Price Performance: A Guide to Technical Indicators - The InvestChronicle
Vera Therapeutics (NASDAQ:VERA) Given “Overweight” Rating at Cantor Fitzgerald - Defense World
Vera Therapeutics Inc Stock (VERA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
4.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):